Clinical trial
DT PACE, Tandem Autologous Transplant, Maintenance Therapy for Waldenstrom's…
NCT00107614 · University of Arkansas, Other · Terminated
Key facts
| NCT number | NCT00107614 |
|---|---|
| Title | DT PACE, Tandem Autologous Transplant, Maintenance Therapy for Waldenstrom's Macroglobulinemia Patients |
| Official title | UARK 2002-10, A Phase II Study of DT PACE Induction, Followed by Tandem Autologous Transplant and Maintenance Therapy for Patients With Advanced and/or Symptomatic Waldenstrom's Macroglobulinemia |
| Lead sponsor | University of Arkansas, Other |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Waldenstrom Macroglobulinemia |
| Intervention type | Drug |
| Interventions | DT PACE + Rituxan |
| Enrollment | 12 |
| Start date | Nov 1, 2002 |
| Primary completion | Feb 1, 2008 |
| Completion | Feb 1, 2008 |
| First posted | Apr 6, 2005 |
| Last update posted | Aug 26, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: